Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib/II Study of Hydroxychloroquine in Metastatic ER-Positive Breast Cancer Progressing on Hormonal Therapy

NCT02414776 is registered in ClinicalTrials.gov with Western Regional Medical Center as lead sponsor.

NCT NCT02414776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02414776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib/II Study of Hydroxychloroquine in Metastatic ER-Positive Breast Cancer Progressing on Hormonal Therapy
Lead sponsor
Western Regional Medical Center
Phase
Phase 1
Overall status
Terminated
Start date
July 31, 2014
Completion date
November 30, 2015
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

estrogen receptor positive breast cancer